Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

TP53 Alterations Confer Increased Risk of Leukemic Transformation and Worse Survival As Compared to High Molecular Risk Mutations in Patients with Myeloproliferative Neoplasms

Blood (2024) 144 (Supplement 1): 243.

https://doi.org/10.1182/blood-2024-206688

Published: 2024

Journal Articles

Genetic Insights into Myeloid Malignancies: A Comparative Analysis of NCCN Guidelines, the World Health Organization Classification, and the ICC System

Roisin Puentes, Jonathan Feld, Christopher G. Smith, Derek D Lyle

Blood (2024) 144 (Supplement 1): 7646.

https://doi.org/10.1182/blood-2024-212344

Published: 2024

Journal Articles

Estimating the Prevalence of Possible Undiagnosed Chronic Myelomonocytic Leukemia in the General Population: An Nhanes Analysis

Dahniel L Sastow, Daniel I. Nathan, Hannah Levavi, Jonathan Feld, Douglas Tremblay

Blood (2024) 144 (Supplement 1): 5182.

https://doi.org/10.1182/blood-2024-197986

Published: 2024

Journal Articles

A Novel Three-Way Translocation Involving ETV6-IL3 Drives AML with Eosinophilia

Ariel Siegel, Joseph Tripodi, Brianna Kelly, Sebastian Elghaity-Beckley, Michelle Becker, Douglas Tremblay, Jonathan Feld, Hannah Levavi, Marina Kremyanskaya, Bridget Kelly Marcellino, Christian Salib, Alla Keyzner, Amy Duffield, John O. Mascarenhas, Vesna Najfeld, Alan Shih

Blood (2024) 144 (Supplement 1): 6098.

https://doi.org/10.1182/blood-2024-203588

Published: 2024

Journal Articles

Bone Marrow-Derived CD57+ NK and NK-like T-Cells Expand in Lower-Risk MDS and Are Implicated in Driving Bone Marrow Failure

Richa Rai, Jonathan Feld, Richard Sheppard, Haocheng Yu, John Cris Ingles, Iyinyeloluwa Okulate, Erin Demakos, Shafinaz Hussein, Kyle Wiatrowski, Rachel Chen, Rachel Lee, Ronaldo Miguel de Real, Geoffrey Kelly, Brian Lee, Travis Dawson, Zhihong Chen, Seunghee Kim-Schulze, Lewis R. Silverman, Amir Horowitz

Blood (2024) 144 (Supplement 1): 5663.

https://doi.org/10.1182/blood-2024-210271

Published: 2024

Journal Articles

Acute Promyelocytic Leukemia in the Molecular Age

Navin Bhatt, Michelle Becker, Juana Martinez, Hannah Levavi, Kyle Farina, Marina Kremyanskaya, Bridget Kelly Marcellino, Alan Shih, Lewis R. Silverman, Vesna Najfeld, John O. Mascarenhas, Douglas Tremblay, Jonathan Feld

Blood (2024) 144 (Supplement 1): 6131.

https://doi.org/10.1182/blood-2024-211957

Published: 2024

Journal Articles

Clinical Utilization and Outcomes of Hypomethylating Agents and Venetoclax in Patients with Myelodysplastic Syndrome - a Multicenter Retrospective Analysis

Blood (2024) 144 (Supplement 1): 3206.

https://doi.org/10.1182/blood-2024-211623

Published: 2024

Journal Articles

Relative Influence of Socioeconomic and Biological Determinants of Outcomes in Adult Acute Lymphoblastic Leukemia

Juana Martinez, Michelle Becker, Megan Metzger, Nagma Shah, Erin Garbes Feliciano, Alberto Busmail Haylock, Navin Bhatt, Nikolaos Spyrou, John O. Mascarenhas, Douglas Tremblay, Jonathan Feld, Marina Kremyanskaya, Michal Bar-Natan, Hannah Levavi

Blood (2024) 144 (Supplement 1): 2798.

https://doi.org/10.1182/blood-2024-212243

Published: 2024

Journal Articles

Predictors of Survival in Core Binding Factor Acute Myeloid Leukemia: An Analysis of the National Cancer Database

Christina Darwish, Grace Van Hyfte, Hannah Levavi, Jonathan Feld, Douglas Tremblay

Blood (2024) 144 (Supplement 1): 4230.

https://doi.org/10.1182/blood-2024-194100

Published: 2024

Journal Articles

Array CGH + SNP in ALL Enhances Detection of Complex Cytogenetic Profiles and Suggests That PRSS1 Loss May Play a Role in Leukemogenesis

Hannah Levavi, Daiva Ahire, Yosef Joseph Rene Amel Riazat-Kesh, Tianxiang Sheng, Dahniel L Sastow, Jonathan Feld, Douglas Tremblay, Marina Kremyanskaya, John Mascarenhas, Vesna Najfeld, Michal Bar-Natan

Blood (2023) 142 (Supplement 1): 6062.

https://doi.org/10.1182/blood-2023-185332

Published: 2023

Journal Articles

Impact of Facility Type on Survival in Chronic Myelomonocytic Leukemia: A Propensity Score Matched, National Cancer Database Analysis

Douglas Tremblay, Grace Van Hyfte, John Mascarenhas, Jonathan Feld

Blood (2023) 142 (Supplement 1): 2431.

https://doi.org/10.1182/blood-2023-179923

Published: 2023

Journal Articles

Phase 1/2 Study of Pacritinib in Combination with Azacitidine in Chronic Myelomonocytic Leukemia

Douglas Tremblay, Alan Shih, Jonathan Feld, Erin Moshier, John Mascarenhas

Blood (2023) 142 (Supplement 1): 3248.

https://doi.org/10.1182/blood-2023-174960

Published: 2023

Journal Articles

The Presence of Ring Chromosomes in Patients with Myeloid Neoplasms Is Predictive of a Poor Outcome

Daniel I. Nathan, Ronald Hoffman, Daiva Ahire, John Mascarenhas, Lewis R. Silverman, Vesna Najfeld, Jonathan Feld

Blood (2023) 142 (Supplement 1): 2940.

https://doi.org/10.1182/blood-2023-179585

Published: 2023

Journal Articles

Establishing a Pathogenic Role for NK Cells As Drivers of Bone Marrow Failure in the Myelodysplastic Syndromes (MDS)

Richa Rai, Jonathan Feld, Iyinyeloluwa Okulate, Stella Melana, Richard Sheppard, Erin Demakos, Shafinaz Hussein, Rachel Chen, Rachel Lee, Ronaldo de Real, Geoffrey Kelly, Brian Lee, Travis Dawson, Zhihong Chen, Vladimir Roudko, Seunghee kim-Schulze, Lewis R R. Silverman, Amir Horowitz

Blood (2023) 142 (Supplement 1): 4078.

https://doi.org/10.1182/blood-2023-181927

Published: 2023

Journal Articles

Impact of Pre-Transplant Molecular and Cytogenetic Remission on Outcomes of Allogeneic Stem Cell Transplant in Patients with Myelodysplastic Syndrome

Shivani Handa, Namrata Sonia Chandhok, Sudhamsh Reddy Desai, Asem Berkalieva, Erin Moshier, Douglas Tremblay, Lewis R. Silverman, Trent Wang, Uroosa Ibrahim, Aditi Shastri, Jonathan Feld

Blood (2023) 142 (Supplement 1): 3239.

https://doi.org/10.1182/blood-2023-190346

Published: 2023

Journal Articles

Venetoclax (VEN) Improves Response Rates but Not Survival in Patients with Chronic Myelomonocytic Leukemia (CMML) Treated with Hypomethylating Agents (HMA): A Multicenter, Propensity Score Analysis

Blood (2023) 142 (Supplement 1): 321.

https://doi.org/10.1182/blood-2023-181795

Published: 2023

Journal Articles

Aberrant Proportion of Monocyte Subsets in Bone Marrow of High-Risk Myelodysplastic Syndrome Patients

Richa Rai, Camille Bigenwald, Jonathan Feld, Stella Melana, Erin P. Demakos, Amir Horowitz, Lewis R. Silverman

Blood (2022) 140 (Supplement 1): 11432–11433.

https://doi.org/10.1182/blood-2022-170922

Published: 2022

Journal Articles

Central Nervous System Specific Characteristics and Outcomes in Acute Myeloid Leukemia Patients with Neurologic Involvement

Dahniel Sastow, Yosef J.R.A Riazat-Kesh, Kyle Farina, Jonathan Feld, Michal Bar-Natan, Alla Keyzner, Lewis R. Silverman, Marina Kremyanskaya, John Mascarenhas, Douglas Tremblay

Blood (2022) 140 (Supplement 1): 11618–11620.

https://doi.org/10.1182/blood-2022-157300

Published: 2022

Journal Articles

Prognostic Impact of Day 14 Bone Marrow (D14 BM Bx) in Acute Myeloid Leukemia (AML) in the Setting of European Leukemianet (ELN) Risk Classification

Metodi Balev, Nicole Zubizarreta, Erin Bresnahan, Jonathan Feld, Marina Kremyanskaya, Alla Keyzner, Alan H. Shih, Bridget K Marcellino, Lewis R. Silverman, Michal Bar-Natan, John Mascarenhas, Douglas Tremblay

Blood (2022) 140 (Supplement 1): 139–140.

https://doi.org/10.1182/blood-2022-167828

Published: 2022

Journal Articles

Combination of Ras Modulator and Azacitidine Impacts Innate Immune Signaling Pathway in MDS-L Cell Line

Richa Rai, Foramben Patel, Jonathan Feld, Stella Melana, Shyamala C. Navada, Rosalie Odchimar-Reissig, Erin P. Demakos, E. Premkumar Reddy, Lewis R. Silverman

Blood (2021) 138 (Supplement 1): 4325.

https://doi.org/10.1182/blood-2021-152764

Published: 2021

NARROW

TP53 Alterations Confer Increased Risk of Leukemic Transformation and Worse Survival As Compared to High Molecular Risk Mutations in Patients with Myeloproliferative Neoplasms

Genetic Insights into Myeloid Malignancies: A Comparative Analysis of NCCN Guidelines, the World Health Organization Classification, and the ICC System

Estimating the Prevalence of Possible Undiagnosed Chronic Myelomonocytic Leukemia in the General Population: An Nhanes Analysis

A Novel Three-Way Translocation Involving ETV6-IL3 Drives AML with Eosinophilia

Bone Marrow-Derived CD57+ NK and NK-like T-Cells Expand in Lower-Risk MDS and Are Implicated in Driving Bone Marrow Failure

Acute Promyelocytic Leukemia in the Molecular Age

Clinical Utilization and Outcomes of Hypomethylating Agents and Venetoclax in Patients with Myelodysplastic Syndrome - a Multicenter Retrospective Analysis

Relative Influence of Socioeconomic and Biological Determinants of Outcomes in Adult Acute Lymphoblastic Leukemia

Predictors of Survival in Core Binding Factor Acute Myeloid Leukemia: An Analysis of the National Cancer Database

Array CGH + SNP in ALL Enhances Detection of Complex Cytogenetic Profiles and Suggests That PRSS1 Loss May Play a Role in Leukemogenesis

Impact of Facility Type on Survival in Chronic Myelomonocytic Leukemia: A Propensity Score Matched, National Cancer Database Analysis

Phase 1/2 Study of Pacritinib in Combination with Azacitidine in Chronic Myelomonocytic Leukemia

The Presence of Ring Chromosomes in Patients with Myeloid Neoplasms Is Predictive of a Poor Outcome

Establishing a Pathogenic Role for NK Cells As Drivers of Bone Marrow Failure in the Myelodysplastic Syndromes (MDS)

Impact of Pre-Transplant Molecular and Cytogenetic Remission on Outcomes of Allogeneic Stem Cell Transplant in Patients with Myelodysplastic Syndrome

Venetoclax (VEN) Improves Response Rates but Not Survival in Patients with Chronic Myelomonocytic Leukemia (CMML) Treated with Hypomethylating Agents (HMA): A Multicenter, Propensity Score Analysis

Aberrant Proportion of Monocyte Subsets in Bone Marrow of High-Risk Myelodysplastic Syndrome Patients

Central Nervous System Specific Characteristics and Outcomes in Acute Myeloid Leukemia Patients with Neurologic Involvement

Prognostic Impact of Day 14 Bone Marrow (D14 BM Bx) in Acute Myeloid Leukemia (AML) in the Setting of European Leukemianet (ELN) Risk Classification

Combination of Ras Modulator and Azacitidine Impacts Innate Immune Signaling Pathway in MDS-L Cell Line

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only